found in a stroke model that the SDH inhibitor malonate reduces acute brain injury in a dose‐dependent manner during reperfusion by targeting succinate oxidation.[19] Because the action of malonate depends on the local pH decrease during ischemia, which facilitates selective uptake by high‐risk tissues via MCT1 during reperfusion,[2] Abe et al. This evidence concerns the gene SDHB and stroke disorder.